Skip to main content
FinSpry Logo
FinSpry
PBH logo
PBH
(NYSE)
Prestige Consumer Healthcare Inc.
$46.05-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Prestige Consumer Healthcare (PBH) Stock Price & Financial Analysis

Prestige Consumer Healthcare Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$45.64 - $47.31
52-Week High$85.29
52-Week Low$42.62
Open$46.02
Volume1.27M
Average Volume (3M)820.02K
Market Cap2.24B
Shares Outstanding47.69M
P/E Ratio (TTM)11.77
Forward P/E13.56
Price to Sales (P/S)2.06
Price to Book (P/B)1.19
EV/EBITDA9.71
Revenue (TTM)1.09B
Net Income (TTM)190.30M
Free Cash Flow (TTM)254.23M
EPS (TTM)$3.91
Profit Margin17.48%
Operating Margin28.42%
Return on Equity (ROE)10.08%
Debt to Equity0.55
50-Day MA$51.58
200-Day MA$60.06
52-Week Change-43.84%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Last Dividend Ex-DateSep 27, 2018

Frequently Asked Questions About Prestige Consumer Healthcare

What is the current stock price for PBH?

As of the latest trading session, PBH stock trades at $46.97. The 52-week range is $42.62–$85.29, with a day range of $45.64–$47.31.

What is the P/E ratio for PBH?

Prestige Consumer Healthcare's trailing P/E ratio is 11.8, meaning investors pay $11.8 for every $1 of annual earnings. The forward P/E is 13.6, reflecting analyst expectations for future earnings. Prestige Consumer Healthcare operates in the Healthcare sector.

Does PBH pay dividends?

Prestige Consumer Healthcare does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PBH?

Based on 3 analysts, the consensus for PBH is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of PBH?

Prestige Consumer Healthcare's market capitalization is $2.24B, classifying it as a mid-cap company. Prestige Consumer Healthcare operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.